Medicare Enrolled
Dr. Amita Saggi, PAC
Medical Physician Assistant · Pleasanton, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saggi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saggi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saggi
Dr. Amita Saggi is a medical physician assistant in Pleasanton, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Saggi performed 181,243 Medicare services across 1,659 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saggi received a total of $1,594 from 22 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saggi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 0% volume in CA
$1,594 industry payments
Medicare Practice Summary
Medicare Utilization ↗181,243
Medicare services
Top 0% in CA for medical physician assistant
1,659
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13,942 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
82,600 | $2 | $12 |
| Pembrolizumab injection (Keytruda) | 30,600 | $43 | $195 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
18,360 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 15,180 | $19 | $81 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
12,750 | $0 | $1 |
| Paclitaxel chemotherapy injection | 11,085 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,531 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,890 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,141 | $8 | $33 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
780 | $74 | $468 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
675 | $13 | $121 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
500 | $12 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $94 | $432 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
438 | $117 | $1,068 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
397 | $70 | $321 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
354 | $2 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
207 | $1 | $3 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 207 | $134 | $593 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
174 | $57 | $387 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
168 | $24 | $224 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
96 | $30 | $276 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
89 | $25 | $173 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
84 | $7 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
78 | $55 | $378 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
59 | $16 | $92 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
57 | $49 | $424 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
55 | $1 | $7 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
42 | $33 | $297 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
41 | $18 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $137 | $523 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
32 | $11 | $78 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
29 | $84 | $390 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
25 | $29 | $302 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.6% high complexity
88.1% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,594
Total received (2021-2024)
Avg $399/year across 4 years
Top 25% in CA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
69
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,269 (79.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325 (20.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$509
2023
$740
2022
$197
2021
$148
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$177
Janssen Biotech, Inc.
$60
Eisai Inc.
$42
Gilead Sciences, Inc.
$40
Rigel Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme LLC
$28
Celgene Corporation
$26
E.R. Squibb & Sons, L.L.C.
$26
PFIZER INC.
$25
BeiGene USA, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Novocure Inc.
$15
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2021-2024) ›
Daiichi Sankyo Inc.
$377
PFIZER INC.
$261
AstraZeneca Pharmaceuticals LP
$125
Amgen Inc.
$124
Merck Sharp & Dohme LLC
$118
E.R. Squibb & Sons, L.L.C.
$96
Takeda Pharmaceuticals U.S.A., Inc.
$67
Janssen Biotech, Inc.
$60
Pharmacyclics LLC, An AbbVie Company
$46
Eisai Inc.
$42
Gilead Sciences, Inc.
$40
GlaxoSmithKline, LLC.
$35
Rigel Pharmaceuticals, Inc.
$29
Celgene Corporation
$26
Pharmacyclics LLC, an AbbVie Company
$23
BeiGene USA, Inc.
$21
SOBI, INC
$20
Ipsen Biopharmaceuticals, Inc
$18
Incyte Corporation
$17
Novartis Pharmaceuticals Corporation
$17
Coherus Biosciences Inc.
$16
Novocure Inc.
$15
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
BLENREP · BRUKINSA · Doptelet · ENHERTU · ERLEADA · EVENITY · Enhertu · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · NINLARO · Nplate · OPDIVO · Optune · Pomalyst · Rezlidhia · SOMATULINE DEPOT · TECVAYLI · Udenyca
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical physician assistants within 10 mi
155
Per 100K population
9.4
County median income
$126,240
Nearest hospital
STANFORD HEALTH CARE TRI-VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saggi is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saggi experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Saggi performed 82,600 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saggi receive payments from pharmaceutical companies?
Yes. Dr. Saggi received a total of $1,594 from 22 companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saggi's costs compare to other medical physician assistants in Pleasanton?
Dr. Saggi's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saggi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Physician Assistants in Pleasanton
Browse medical physician assistants in Pleasanton ranked by procedure volume and transparency data.
Highest volume
Top Medical Physician Assistants in CA
Medical physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Physician Assistants in CA
Which CA medical physician assistants receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology